Natixis Advisors LLC Has $1.77 Million Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Key Points

• Natixis Advisors LLC increased its ownership in Option Care Health, Inc. by 33.8%, now holding a total of 50,654 shares valued at approximately $1.77 million.
• The company's recent earnings report showed revenue growth of 15.4% year-over-year, with earnings surpassing analysts' expectations by posting $0.41 EPS for the quarter.
• Consensus analyst ratings for Option Care Health are favorable, with a "Moderate Buy" rating and an average price target of $35.75.

Natixis Advisors LLC raised its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 33.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 50,654 shares of the company's stock after acquiring an additional 12,802 shares during the period. Natixis Advisors LLC's holdings in Option Care Health were worth $1,770,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Compass Wealth Management LLC grew its stake in shares of Option Care Health by 8.9% during the 1st quarter. Compass Wealth Management LLC now owns 166,078 shares of the company's stock worth $5,804,000 after purchasing an additional 13,600 shares during the period. Bessemer Group Inc. raised its stake in shares of Option Care Health by 62.3% during the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after buying an additional 599 shares during the period. Principal Financial Group Inc. raised its stake in shares of Option Care Health by 1.4% during the 1st quarter. Principal Financial Group Inc. now owns 485,871 shares of the company's stock worth $16,981,000 after buying an additional 6,616 shares during the period. Wealth Enhancement Advisory Services LLC lifted its position in shares of Option Care Health by 25.7% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company's stock valued at $289,000 after acquiring an additional 1,691 shares in the last quarter. Finally, GAMMA Investing LLC lifted its position in shares of Option Care Health by 307.1% in the first quarter. GAMMA Investing LLC now owns 3,192 shares of the company's stock valued at $112,000 after acquiring an additional 2,408 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Stock Performance

OPCH traded down $0.05 during trading hours on Wednesday, hitting $28.49. The company's stock had a trading volume of 207,317 shares, compared to its average volume of 1,836,536. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The firm has a market capitalization of $4.62 billion, a PE ratio of 22.78, a PEG ratio of 1.76 and a beta of 0.79. The company has a 50-day simple moving average of $30.50 and a 200 day simple moving average of $31.91. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.35 billion. During the same quarter last year, the company posted $0.30 earnings per share. The company's revenue for the quarter was up 15.4% compared to the same quarter last year. As a group, sell-side analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on OPCH. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. Citigroup reiterated an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. JMP Securities increased their price target on shares of Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research note on Thursday, July 31st. Finally, Barrington Research reiterated an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research note on Thursday, July 10th. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, Option Care Health has a consensus rating of "Moderate Buy" and a consensus price target of $35.75.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.